Human/JJ
neutrophil/NN
elastase/NN
proteolytically/RB
activates/VBZ
the/DT
platelet/NN
integrin/NN
alphaIIbbeta3/NN
through/IN
cleavage/NN
of/IN
the/DT
carboxyl/NN
terminus/NN
of/IN
the/DT
alphaIIb/NN
subunit/NN
heavy/JJ
chain/NN
./.
=====
Involvement/NN
in/IN
the/DT
potentiation/NN
of/IN
platelet/NN
aggregation/NN
./.

Neutrophil/NN
elastase/NN
(/(
NE/NN
)/)
and/CC
cathepsin/NN
G/NN
are/VBP
two/CD
serine/NN
proteinases/NNS
released/VBN
concomitantly/RB
by/IN
stimulated/VBN
polymorphonuclear/JJ
neutrophils/NNS
./.
=====
We/PRP
previously/RB
demonstrated/VBD
that/IN
while/IN
NE/NN
by/IN
itself/PRP
does/VBZ
not/RB
activate/VB
human/JJ
platelets/NNS
,/,
it/PRP
strongly/RB
enhances/VBZ
the/DT
weak/JJ
aggregation/NN
induced/VBN
by/IN
a/DT
threshold/NN
concentration/NN
of/IN
cathepsin/NN
G/NN
(/(
threshold/NN
of/IN
cathepsin/NN
G/NN
)/)
(/(
Renesto/NNP
,/,
P./NNP
,/,
and/CC
Chignard/NNP
,/,
M./NNP
(/(
1993/CD
)/)
Blood/NNP
82/CD
,/,
139-144/CD
)/)
./.
=====
The/DT
aim/NN
of/IN
this/DT
study/NN
was/VBD
to/TO
delineate/VB
the/DT
molecular/JJ
mechanisms/NNS
involved/VBN
in/IN
this/DT
potentiation/NN
process/NN
./.
=====
Two/CD
main/JJ
pieces/NNS
of/IN
data/NNS
prompted/VBD
us/PRP
to/TO
focus/VB
on/IN
the/DT
activation/NN
of/IN
the/DT
platelet/NN
fibrinogen/NN
receptor/NN
,/,
the/DT
alphaIIbbeta3/NN
integrin/NN
./.
=====
First/RB
,/,
previous/JJ
studies/NNS
have/VBP
shown/VBN
this/DT
integrin/NN
to/TO
be/VB
particularly/RB
prone/JJ
to/TO
proteolytic/JJ
regulation/NN
of/IN
its/PRP$
function/NN
./.
=====
Second/RB
,/,
we/PRP
found/VBD
that/IN
the/DT
potentiating/NN
activity/NN
of/IN
NE/NN
on/IN
the/DT
threshold/NN
of/IN
cathepsin/NN
G-induced/JJ
platelet/NN
aggregation/NN
was/VBD
strictly/RB
dependent/JJ
on/IN
the/DT
presence/NN
of/IN
exogenous/JJ
fibrinogen/NN
./.
=====
Using/VBG
flow/NN
cytometry/NN
analysis/NN
,/,
NE/NN
was/VBD
shown/VBN
to/TO
trigger/VB
a/DT
time-dependent/JJ
binding/NN
of/IN
PAC-1/NN
and/CC
AP-5/NN
,/,
two/CD
monoclonal/JJ
antibodies/NNS
specific/JJ
for/IN
the/DT
activated/VBN
and/CC
ligand-occupied/JJ
conformers/NNS
of/IN
alphaIIbbeta3/NN
./.
=====
Furthermore/RB
,/,
the/DT
potentiated/JJ
aggregation/NN
was/VBD
shown/VBN
to/TO
result/VB
from/IN
an/DT
increased/VBN
capacity/NN
of/IN
platelets/NNS
to/TO
bind/VB
fibrinogen/NN
./.
=====
Indeed/RB
,/,
the/DT
combination/NN
of/IN
NE/NN
and/CC
threshold/NN
of/IN
cathepsin/NN
G/NN
increased/VBD
the/DT
binding/NN
of/IN
PAC-1/NN
approximately/RB
5.5-fold/RB
over/IN
basal/JJ
values/NNS
measured/VBN
on/IN
nontreated/JJ
platelets/NNS
,/,
whereas/IN
this/DT
binding/NN
raised/VBD
only/RB
by/IN
approximately/RB
3-fold/RB
in/IN
threshold/NN
of/IN
cathepsin/NN
G-stimulated/JJ
platelets/NNS
(/(
p/NN
</JJR
0.05/CD
)/)
./.
=====
By/IN
contrast/NN
,/,
phosphatidic/JJ
acid/NN
accumulation/NN
,/,
pleckstrin/NN
phosphorylation/NN
,/,
and/CC
calcium/NN
mobilization/NN
produced/VBN
by/IN
the/DT
combination/NN
of/IN
NE/NN
and/CC
threshold/NN
of/IN
cathepsin/NN
G/NN
were/VBD
not/RB
significantly/RB
different/JJ
from/IN
those/DT
measured/VBN
with/IN
threshold/NN
of/IN
cathepsin/NN
G/NN
alone/RB
(/(
p/NN
>/JJR
0.05/CD
)/)
,/,
indicating/VBG
that/IN
the/DT
phospholipase/NN
C/protein/NN
kinase/NN
C/NN
pathway/NN
is/VBZ
not/RB
involved/VBN
in/IN
the/DT
potentiation/NN
of/IN
aggregation/NN
./.
=====
The/DT
foregoing/JJ
data/NNS
,/,
as/RB
well/RB
as/IN
the/DT
requirement/NN
of/IN
catalytically/RB
active/JJ
NE/NN
to/TO
trigger/VB
alphaIIbbeta3/NN
activation/NN
and/CC
potentiate/VB
threshold/NN
of/IN
cathepsin/NN
G-initiated/JJ
platelet/NN
aggregation/NN
,/,
led/VBD
us/PRP
to/TO
examine/VB
whether/IN
the/DT
structure/NN
of/IN
this/DT
integrin/NN
was/VBD
affected/VBN
by/IN
NE/NN
./.
=====
Immunoblot/NN
and/CC
flow/NN
cytometry/NN
analysis/NN
revealed/VBD
a/DT
limited/JJ
proteolysis/NN
of/IN
the/DT
carboxyl/NN
terminus/NN
of/IN
the/DT
alphaIIb/NN
subunit/NN
heavy/JJ
chain/NN
(/(
alphaIIbH/NN
)/)
,/,
as/IN
judged/VBN
by/IN
the/DT
disappearance/NN
of/IN
the/DT
epitope/NN
for/IN
the/DT
monoclonal/JJ
antibody/JJ
PMI-1/NN
./.
=====
Mass/JJ
spectrometry/NN
studies/NNS
performed/VBN
on/IN
a/DT
synthetic/JJ
peptide/NN
mapping/VBG
over/IN
the/DT
cleavage/NN
domain/NN
of/IN
alphaIIbH/NN
predicted/VBD
the/DT
site/NN
of/IN
proteolysis/NN
as/IN
located/JJ
between/IN
Val837/NN
and/CC
Asp838/NN
./.
=====
Treatment/NN
by/IN
NE/NN
of/IN
ATP-depleted/JJ
platelets/NNS
or/CC
Chinese/JJ
hamster/NN
ovary/NN
cells/NNS
expressing/VBG
human/JJ
recombinant/NN
alphaIIbbeta3/NN
clearly/RB
established/VBD
that/IN
activation/NN
of/IN
the/DT
integrin/NN
was/VBD
independent/JJ
of/IN
signal/NN
transduction/NN
events/NNS
and/CC
was/VBD
concomitant/JJ
with/IN
the/DT
proteolysis/NN
of/IN
alphaIIbH/NN
./.